Schizophrenia: a review of neuropharmacology
- 1 July 2004
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science
- Vol. 173 (3), 155-159
- https://doi.org/10.1007/bf03167931
Abstract
The last few decades have seen significant advances in our understanding of the neurochemical basis of schizophrenia.Keywords
This publication has 20 references indexed in Scilit:
- Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophreniaMolecular Psychiatry, 2005
- Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophreniaMolecular Psychiatry, 2004
- Dopamine Partial AgonistsCNS Drugs, 2004
- Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disordersPsychopharmacology, 2003
- Implications for Altered Glutamate and GABA Metabolism in the Dorsolateral Prefrontal Cortex of Aged Schizophrenic PatientsAmerican Journal of Psychiatry, 2002
- Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A2A and dopamine D2 receptorsNeuroscience Letters, 2002
- Functional neuroanatomy of the ventral striopallidal GABA pathwayJournal of Neuroscience Methods, 2001
- Dopamine D2 Receptor Occupancy Is a Common Mechanism Underlying Animal Models of Antipsychotics and Their Clinical EffectsNeuropsychopharmacology, 2001
- Amygdaloid N-methyl-d-aspartate and γ-aminobutyric acidA receptors regulate sensorimotor gating in a dopamine-dependent way in ratsNeuroscience, 2000
- The 100-year epidemiology of schizophreniaSchizophrenia Research, 1997